Increased nitric oxide inactivation by reactive oxygen species in lead- induced hypertension

Kidney International

Volumn 56, Issue 4, 1999, Pages 1492-1498

  Vaziri, Nosratola D ^a,b   Liang, Kaihui ^a   Ding, Yaoxian ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidant; Hypertension; Lead; Oxidative stress; Tocopherol; Vitamin E

Indexed keywords

3 NITROTYROSINE; ALPHA TOCOPHEROL; CREATININE; LEAD ACETATE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE CLEARANCE; DIET SUPPLEMENTATION; HYPERTENSION; MALE; NONHUMAN; OXIDATION; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; TISSUE DISTRIBUTION; URINARY EXCRETION;

EID: 0032822744     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00670.x     Document Type: Conference Paper

References (27)

1. SHARP DS, BECKER CE, SMITH AH: Chronic low-level lead exposure: Its role in the pathogenesis of hypertension. Med Toxicol 2:210-232, 1987
2. SHARP DS, OSTERLOH J, BECKER CE, BERNARD B, SMITH AH, FISHER JM, SYME SL, HOLMAN BL, JOHNSTON T: Blood pressure and blood lead concentration in bus drivers. Environ Health Perspect 78:131-137, 1988
3. HARLAN WR: The relationship of blood lead levels to blood pressure in the U.S. population. Environ Health Perspect 78:9-13, 1998
4. KHALH-MANESH F, GONICK HC, WEILER EW, PRINS B, WEBER MA, PURDY R, REN Q: Effect of chelation treatment with dimercaptosuccinic acid (DMSA) on lead-related blood pressure changes. Environ Res 65:86-99, 1994
5. KHALH-MANESH F, GONICK HC, WEILER EW, PRINS B, WEBER MA, PURDY RE: Lead-induced hypertension: Possible role of endothelial factors. Am J Hypertens 6:723-729, 1993
6. GONICK HC, DING Y, BONDY SC, NI Z, VAZIRI ND: Lead-induced hypertension: Interplay of nitric oxide and reactive oxygen species. Hypertension 30:1487-1492, 1997
7. NOWACK R, WIECEK A, EXNER B, GRETZ N, RITZ. E: Chronic lead exposure in rats; Effects on blood pressure. Eur J Clin Invest 23:433-443, 1993
8. VAZIRI ND, DING Y, NI Z, GONICK HC: Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: Effect of lazaroid therapy. Kidney Int 52:1042-1046, 1997
9. DING Y, VAZIRI ND, GONICK HC: Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside. Environ Res 76:107-113, 1998
10. HALLIWELL, B: What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 411:157-160, 1997
11. EISERICH JP, BUTLER J, VAN DER VLIET A, CROSS CE, HALLIWELL B: Nitric oxide rapidly scavenges tyrosine and tryptophan radicals. Biochem J 310:745-749, 1995
12. EISERICH JP, HRISTOVA M, CROSS CE, JONES AD, FREEMAN BA, HALLIWELL B, VAN DER VLIETA: Formation of nitric oxide-derived inflammatory oxidants by mycloperoxidase in neutrophils. Nature 391:393-397, 1998
13. VAZIRI ND, OVEISI F, DING Y: Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int 53:1748-1754, 1998
14. VAZIRI ND, NI Z, WANG XQ, OVEISI F, ZHOU XJ: Downregulation of nitric oxide synthase in chronic renal insufficiency: Role of excess PTH. Am J Physiol 274:F642-F649, 1998
15. SU JH, DENG G, COTMAN CW: Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain. Brain Res 774:193-199, 1997
16. KHALH-MANESH F, GONICK HC, COHEN AH: Experimental model of lead nephropathy. III. Continuous low-level lead administration. Arch Environ Health 48:271-278, 1993
17. VAZIRI ND, DING Y, NI Z: Nitric oxide synthase expression in the course of lead-induced hypertension. Hypertension (in press)
18. DARLEY-USMAR V, HALLIWELL B: Blood radicals: Reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm Res 13:649-662, 1996
19. BECKMAN JS, CHEN J, ISCHIROPOULOS H, CROW JP: Oxidative chemistry of peroxynitrite. Methods Enzymol 233:229-240, 1994
20. PRYOR WA, SQUADRITO GL: The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide. Am J Physiol 268:L699-L722, 1995
21. UPPU RM, SQUADRITO GL, PRYOR WA: Acceleration of peroxynitrite oxidations by carbon dioxide. Arch Biochem Biophys 327:335-343, 1996
22. VAN DER VLIET A, SMITH D, O'NEILL CA, KAUR H, DARLEY-USMAR V, CROSS CE, HALLIWELL B: Interactions of peroxynitrite with human plasma and its constituents: Oxidative damage and antioxidant depletion. Biochem J 303:295-301, 1994
23. SPENCER JP, WONG J, JENNER A, ARUOMA OI, CROSS CE, HALLIWELL B: Base modification and strand breakage in isolated calf thymus DNA and in DNA from human skin epidermal keratinocytes exposed to peroxynitrite or 3-morpholinosydnonimine. Chem Res Toxicol 9:1152-1158, 1996
24. RADI R, BECKMAN JS, BUSH KM, FREEMAN BA: Peroxynitrite oxidation of sulfhydryls: The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266:4244-4250, 1991
25. KOPPENOL WH, MORENO JJ, PRYOR WA, ISCHIROPOULOS H, BECKMAN JS: Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol 5:834-842, 1992
26. YERMILOV V, YOSHIE Y, RUBIO J, OHSHIMA H: Effects of carbon dioxide/bicarbonate on induction of DNA single-strand breaks and formation of 8-nitroguanine, 8-oxoguanine and base-propenal mediated by peroxynitrite. FEBS Lett 399:67-70, 1996
27. ZHU S, HADDAD IY, MATALON S: Nitration of surfactant protein A (SP-A) tyrosine residues results in decreased mannose binding ability. Arch Biochem Biophys 333:282-290, 1996